150 related articles for article (PubMed ID: 33736628)
1. Cervical cancer in women under 30 years of age in Norway: a population-based cohort study.
Gravdal BH; Lönnberg S; Skare GB; Sulo G; Bjørge T
BMC Womens Health; 2021 Mar; 21(1):110. PubMed ID: 33736628
[TBL] [Abstract][Full Text] [Related]
2. Screening histories of women with CIN 2/3 compared with women diagnosed with invasive cervical cancer: a retrospective analysis of the Norwegian Coordinated Cervical Cancer Screening Program.
Nygård JF; Nygård M; Skare GB; Thoresen SØ
Cancer Causes Control; 2005 May; 16(4):463-74. PubMed ID: 15953989
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of cervical screening after age 60 years according to screening history: Nationwide cohort study in Sweden.
Wang J; Andrae B; Sundström K; Ploner A; Ström P; Elfström KM; Dillner J; Sparén P
PLoS Med; 2017 Oct; 14(10):e1002414. PubMed ID: 29065127
[TBL] [Abstract][Full Text] [Related]
4. Success of a cervical cancer screening program: trends in incidence in songkhla, southern Thailand, 1989-2010, and prediction of future incidences to 2030.
Sriplung H; Singkham P; Iamsirithaworn S; Jiraphongsa C; Bilheem S
Asian Pac J Cancer Prev; 2014; 15(22):10003-8. PubMed ID: 25520060
[TBL] [Abstract][Full Text] [Related]
5. The effect of age at immigration on cervical cancer incidence: a population-based cohort study of 1 486 438 Israeli women.
Raz Y; Keinan-Boker L; Goren S; Soen-Grisaru G; Cohen D; Grisaru D
Int J Gynecol Cancer; 2019 Mar; 29(3):492-496. PubMed ID: 30833437
[TBL] [Abstract][Full Text] [Related]
6. Trends and Age-Period-Cohort Effects on the Incidence and Mortality Rate of Cervical Cancer in Korea.
Moon EK; Oh CM; Won YJ; Lee JK; Jung KW; Cho H; Jun JK; Lim MC; Ki M
Cancer Res Treat; 2017 Apr; 49(2):526-533. PubMed ID: 27586676
[TBL] [Abstract][Full Text] [Related]
7. Incidence, mortality and survival from invasive cervical cancer in Vaud, Switzerland, 1974-1991.
Levi F; La Vecchia C; Randimbison L; Te VC
Ann Oncol; 1994 Oct; 5(8):747-52. PubMed ID: 7826908
[TBL] [Abstract][Full Text] [Related]
8. Cervical cancer prevented by screening: Long-term incidence trends by morphology in Norway.
Lönnberg S; Hansen BT; Haldorsen T; Campbell S; Schee K; Nygård M
Int J Cancer; 2015 Oct; 137(7):1758-64. PubMed ID: 25833121
[TBL] [Abstract][Full Text] [Related]
9. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
[TBL] [Abstract][Full Text] [Related]
10. Second cancers among 104,760 survivors of cervical cancer: evaluation of long-term risk.
Chaturvedi AK; Engels EA; Gilbert ES; Chen BE; Storm H; Lynch CF; Hall P; Langmark F; Pukkala E; Kaijser M; Andersson M; Fosså SD; Joensuu H; Boice JD; Kleinerman RA; Travis LB
J Natl Cancer Inst; 2007 Nov; 99(21):1634-43. PubMed ID: 17971527
[TBL] [Abstract][Full Text] [Related]
11. A Population-based Study of Invasive Cervical Cancer Patients in Beijing: 1993-2008.
Wang T; Wu MH; Wu YM; Zhang WY
Chin Med J (Engl); 2015 Dec; 128(24):3298-304. PubMed ID: 26668143
[TBL] [Abstract][Full Text] [Related]
12. Assessing Impact of HPV Vaccination on Cervical Cancer Incidence among Women Aged 15-29 Years in the United States, 1999-2017: An Ecologic Study.
Mix JM; Van Dyne EA; Saraiya M; Hallowell BD; Thomas CC
Cancer Epidemiol Biomarkers Prev; 2021 Jan; 30(1):30-37. PubMed ID: 33082207
[TBL] [Abstract][Full Text] [Related]
13. Histopathologic subtyping of cervical adenocarcinoma reveals increasing incidence rates of endometrioid tumors in all age groups: a population based study with review of all nonsquamous cervical carcinomas in Norway from 1966 to 1970, 1976 to 1980, and 1986 to 1990.
Alfsen GC; Thoresen SO; Kristensen GB; Skovlund E; Abeler VM
Cancer; 2000 Sep; 89(6):1291-9. PubMed ID: 11002225
[TBL] [Abstract][Full Text] [Related]
14. Recent increase in incidence of cervical precancerous lesions in Norway: Nationwide study from 1992 to 2016.
Orumaa M; Leinonen MK; Campbell S; Møller B; Myklebust TÅ; Nygård M
Int J Cancer; 2019 Nov; 145(10):2629-2638. PubMed ID: 30734284
[TBL] [Abstract][Full Text] [Related]
15. [Are analyses of cytological cervix smears from young women more harmful than beneficial?].
Skjeldestad FE; Hagen B; Hagmar B; Iversen OE; Juvkam KH; Steen R; Thoresen S; Hareide B
Tidsskr Nor Laegeforen; 2007 Jun; 127(13):1782-5. PubMed ID: 17599128
[TBL] [Abstract][Full Text] [Related]
16. Effect of ageing on cervical or vaginal cancer in Swedish women previously treated for cervical intraepithelial neoplasia grade 3: population based cohort study of long term incidence and mortality.
Strander B; Hällgren J; Sparén P
BMJ; 2014 Jan; 348():f7361. PubMed ID: 24423603
[TBL] [Abstract][Full Text] [Related]
17. Screening frequency and atypical cells and the prediction of cervical cancer risk.
Chen YY; You SL; Koong SL; Liu J; Chen CA; Chen CJ;
Obstet Gynecol; 2014 May; 123(5):1003-1011. PubMed ID: 24785853
[TBL] [Abstract][Full Text] [Related]
18. Trends in cervical cancer incidence and survival in Estonia from 1995 to 2014.
Ojamaa K; Innos K; Baburin A; Everaus H; Veerus P
BMC Cancer; 2018 Nov; 18(1):1075. PubMed ID: 30404606
[TBL] [Abstract][Full Text] [Related]
19. Temporal Changes in Incidence Rates of the Most Common Gynecological Cancers in the Female Population in Central Serbia.
Stojanovic MM; Rancic NK; Andjelković Apostolović MR; Ignjatović AM; Stojanovic DR; Mitic Lakusic VR; Ilic MV
Medicina (Kaunas); 2022 Feb; 58(2):. PubMed ID: 35208629
[No Abstract] [Full Text] [Related]
20. Cervical Cancer in Khon Kaen, Thailand: Analysis of 1990-2014 Incidence Data and Prediction of Future Trends.
Saenrueang T; Promthet S; Kamsa-Ard S; Pengsaa P
Asian Pac J Cancer Prev; 2019 Feb; 20(2):369-375. PubMed ID: 30803194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
